Marina Garden Nursing Center | |
3201 Fernside Blvd., Alameda, California 94501 | |
(510) 523-2363 | |
Name | Marina Garden Nursing Center |
---|---|
Location | 3201 Fernside Blvd., Alameda, California |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 32 |
Occupancy Rate | 83.44% |
Medicare ID (CCN) | 555461 |
Legal Business Name | Marina Garden Nursing Center, Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1699770867 |
Organization Name | MARINA GARDEN NURSING CENTER, INC. |
Doing Business As | MARINA GARDEN NURSING CENTER |
Address | 3201 Fernside Blvd, Alameda, CA 94501 |
Phone Number | 510-523-2363 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
A study from a National Institutes of Health research network found that an early treatment to prevent severe newborn jaundice in extremely early preterm infants reduced the infants' rate of brain injury, a serious complication of severe jaundice.
A new study by two researchers in the University at Buffalo School of Social Work has shown that parents who chronically neglect their children contribute to the likelihood that they will develop aggressive and delinquent tendencies later in adolescence, and the one factor that links neglect with those behaviors appears to be poor social skills.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today top-line results from a Phase IIb trial with ALN-RSV01 for the treatment of respiratory syncytial virus (RSV) infection in lung transplant patients.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
A study from a National Institutes of Health research network found that an early treatment to prevent severe newborn jaundice in extremely early preterm infants reduced the infants' rate of brain injury, a serious complication of severe jaundice.
A new study by two researchers in the University at Buffalo School of Social Work has shown that parents who chronically neglect their children contribute to the likelihood that they will develop aggressive and delinquent tendencies later in adolescence, and the one factor that links neglect with those behaviors appears to be poor social skills.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today top-line results from a Phase IIb trial with ALN-RSV01 for the treatment of respiratory syncytial virus (RSV) infection in lung transplant patients.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 18.75 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.43 | 5.51 |